| Literature DB >> 31193141 |
Anna Trzeciecka1, David T Stark2, Jacky M K Kwong2, Maria Piqueras1, Sanjoy K Bhattacharya1, Joseph Caprioli2.
Abstract
In adult mammals, retinal ganglion cells (RGCs) fail to regenerate following damage. As a result, RGCs die after acute injury and in progressive degenerative diseases such as glaucoma; this can lead to permanent vision loss and, eventually, blindness. Lipids are crucial for the development and maintenance of cell membranes, myelin sheaths, and cellular signaling pathways, however, little is known about their role in axon injury and repair. Studies examining changes to the lipidome during optic nerve (ON) regeneration could greatly inform treatment strategies, yet these are largely lacking. Experimental animal models of ON regeneration have facilitated the exploration of the molecular determinants that affect RGC axon regeneration. Here, we analyzed lipid profiles of the ON and retina in an ON crush rat model using liquid chromatography-mass spectrometry. Furthermore, we investigated lipidome changes after ON crush followed by intravitreal treatment with Zymosan, a yeast cell wall derivative known to enhance RGC regeneration. This data is available at the NIH Common Fund's Metabolomics Data Repository and Coordinating Center (supported by NIH grant, U01-DK097430) website, the Metabolomics Workbench, http://www.metabolomicsworkbench.org, where it has been assigned Project ID: PR000661. The data can be accessed directly via it's Project DOI: doi: 10.21,228/M87D53.Entities:
Keywords: Lipid profile; Optic nerve; Optic nerve crush; Regeneration; Retina; Zymosan
Year: 2019 PMID: 31193141 PMCID: PMC6517575 DOI: 10.1016/j.dib.2019.103950
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1Lipid profiling of the optic nerve (ON) regeneration. (a) The dataset consists of the following experimental groups: intact control, ON crush (followed by intravitreal injection of the vehicle) and inflammation-induced ON regeneration (ON crush followed by intravitreal injection of Zymosan + CPT-cAMP). ONs were harvested 3, 7, 14 days post-crush and retinas 7, 14 days post-crush. (b) In the longitudinal sections of rat ON, Zymosan + CPT-cAMP increases expression of a marker of axon regeneration, GAP43, distal to the crush site (*). (c) Following methanol-chloroform-based extraction, lipids were separated by C30 high-performance liquid chromatography (HPLC) system using Accela 600 pump and measured in (+)/(−) heated electrospray (HESI) ionization mode using a Q Exactive mass spectrometer. Lipidome identification and relative quantification were performed in LipidSearch, followed by statistical analysis in MetaboAnalyst.
Fig. 2Schematic diagram of optic nerve crush and intravitreal injection.
Samples list.
| Data | Subject | Eye | Tissue | Day | ON crush | IVI injection | Lipid extraction protocol | LC-MS protocol | ESI mode | |
|---|---|---|---|---|---|---|---|---|---|---|
| PBS | Zymosan | |||||||||
| DS_1_POS | Rat_1 | OD | ON | 3 | – | – | – | + | + | + |
| DS_1_NEG | Rat_1 | OD | ON | 3 | – | – | – | + | + | – |
| DS_2_POS | Rat_2 | OD | ON | 3 | – | – | – | + | + | + |
| DS_2_NEG | Rat_2 | OD | ON | 3 | – | – | – | + | + | – |
| DS_3_POS | Rat_3 | OD | ON | 3 | – | – | – | + | + | + |
| DS_3_NEG | Rat_3 | OD | ON | 3 | – | – | – | + | + | – |
| DS_4_POS | Rat_1 | OS | ON | 3 | + | + | – | + | + | + |
| DS_4_NEG | Rat_1 | OS | ON | 3 | + | + | – | + | + | – |
| DS_5_POS | Rat_2 | OS | ON | 3 | + | + | – | + | + | + |
| DS_5_NEG | Rat_2 | OS | ON | 3 | + | + | – | + | + | – |
| DS_6_POS | Rat_3 | OS | ON | 3 | + | + | – | + | + | + |
| DS_6_NEG | Rat_3 | OS | ON | 3 | + | + | – | + | + | – |
| DS_7_POS | Rat_4 | OS | ON | 3 | + | – | + | + | + | + |
| DS_7_NEG | Rat_4 | OS | ON | 3 | + | – | + | + | + | – |
| DS_8_POS | Rat_5 | OS | ON | 3 | + | – | + | + | + | + |
| DS_8_NEG | Rat_5 | OS | ON | 3 | + | – | + | + | + | – |
| DS_9_POS | Rat_6 | OS | ON | 3 | + | – | + | + | + | + |
| DS_9_NEG | Rat_6 | OS | ON | 3 | + | – | + | + | + | – |
| DS_10_POS | Rat_7 | OD | ON | 7 | – | – | – | + | + | + |
| DS_10_NEG | Rat_7 | OD | ON | 7 | – | – | – | + | + | – |
| DS_11_POS | Rat_8 | OD | ON | 7 | – | – | – | + | + | + |
| DS_11_NEG | Rat_8 | OD | ON | 7 | – | – | – | + | + | – |
| DS_12_POS | Rat_9 | OD | ON | 7 | – | – | – | + | + | + |
| DS_12_NEG | Rat_9 | OD | ON | 7 | – | – | – | + | + | – |
| DS_13_POS | Rat_7 | OS | ON | 7 | + | + | – | + | + | + |
| DS_13_NEG | Rat_7 | OS | ON | 7 | + | + | – | + | + | – |
| DS_14_POS | Rat_8 | OS | ON | 7 | + | + | – | + | + | + |
| DS_14_NEG | Rat_8 | OS | ON | 7 | + | + | – | + | + | – |
| DS_15_POS | Rat_9 | OS | ON | 7 | + | + | – | + | + | + |
| DS_15_NEG | Rat_9 | OS | ON | 7 | + | + | – | + | + | – |
| DS_16_POS | Rat_10 | OS | ON | 7 | + | – | + | + | + | + |
| DS_16_NEG | Rat_10 | OS | ON | 7 | + | – | + | + | + | – |
| DS_17_POS | Rat_11 | OS | ON | 7 | + | – | + | + | + | + |
| DS_17_NEG | Rat_11 | OS | ON | 7 | + | – | + | + | + | – |
| DS_18_POS | Rat_12 | OS | ON | 7 | + | – | + | + | + | + |
| DS_18_NEG | Rat_12 | OS | ON | 7 | + | – | + | + | + | – |
| DS_19_POS | Rat_7 | OD | retina | 7 | – | – | – | + | + | + |
| DS_19_NEG | Rat_7 | OD | retina | 7 | – | – | – | + | + | – |
| DS_20_POS | Rat_8 | OD | retina | 7 | – | – | – | + | + | + |
| DS_20_NEG | Rat_8 | OD | retina | 7 | – | – | – | + | + | – |
| DS_21_POS | Rat_9 | OD | retina | 7 | – | – | – | + | + | + |
| DS_21_NEG | Rat_9 | OD | retina | 7 | – | – | – | + | + | – |
| DS_22_POS | Rat_7 | OS | retina | 7 | + | + | – | + | + | + |
| DS_22_NEG | Rat_7 | OS | retina | 7 | + | + | – | + | + | – |
| DS_23_POS | Rat_8 | OS | retina | 7 | + | + | – | + | + | + |
| DS_23_NEG | Rat_8 | OS | retina | 7 | + | + | – | + | + | – |
| DS_24_POS | Rat_9 | OS | retina | 7 | + | + | – | + | + | + |
| DS_24_NEG | Rat_9 | OS | retina | 7 | + | + | – | + | + | – |
| DS_25_POS | Rat_10 | OS | retina | 7 | + | – | + | + | + | + |
| DS_25_NEG | Rat_10 | OS | retina | 7 | + | – | + | + | + | – |
| DS_26_POS | Rat_11 | OS | retina | 7 | + | – | + | + | + | + |
| DS_26_NEG | Rat_11 | OS | retina | 7 | + | – | + | + | + | – |
| DS_27_POS | Rat_12 | OS | retina | 7 | + | – | + | + | + | + |
| DS_27_NEG | Rat_12 | OS | retina | 7 | + | – | + | + | + | – |
| DS_28_POS | Rat_13 | OD | ON | 14 | – | – | – | + | + | + |
| DS_28_NEG | Rat_13 | OD | ON | 14 | – | – | – | + | + | – |
| DS_29_POS | Rat_14 | OD | ON | 14 | – | – | – | + | + | + |
| DS_29_NEG | Rat_14 | OD | ON | 14 | – | – | – | + | + | – |
| DS_30_POS | Rat_15 | OD | ON | 14 | – | – | – | + | + | + |
| DS_30_NEG | Rat_15 | OD | ON | 14 | – | – | – | + | + | – |
| DS_31_POS | Rat_13 | OS | ON | 14 | + | + | – | + | + | + |
| DS_31_NEG | Rat_13 | OS | ON | 14 | + | + | – | + | + | – |
| DS_32_POS | Rat_14 | OS | ON | 14 | + | + | – | + | + | + |
| DS_32_NEG | Rat_14 | OS | ON | 14 | + | + | – | + | + | – |
| DS_33_POS | Rat_15 | OS | ON | 14 | + | + | – | + | + | + |
| DS_33_NEG | Rat_15 | OS | ON | 14 | + | + | – | + | + | – |
| DS_34_POS | Rat_16 | OS | ON | 14 | + | – | + | + | + | + |
| DS_34_NEG | Rat_16 | OS | ON | 14 | + | – | + | + | + | – |
| DS_35_POS | Rat_17 | OS | ON | 14 | + | – | + | + | + | + |
| DS_35_NEG | Rat_17 | OS | ON | 14 | + | – | + | + | + | – |
| DS_36_POS | Rat_18 | OS | ON | 14 | + | – | + | + | + | + |
| DS_36_NEG | Rat_18 | OS | ON | 14 | + | – | + | + | + | – |
| DS_37_POS | Rat_19 | OS | ON | 14 | + | – | + | + | + | + |
| DS_37_NEG | Rat_19 | OS | ON | 14 | + | – | + | + | + | – |
| DS_38_POS | Rat_13 | OD | retina | 14 | – | – | – | + | + | + |
| DS_38_NEG | Rat_13 | OD | retina | 14 | – | – | – | + | + | – |
| DS_39_POS | Rat_14 | OD | retina | 14 | – | – | – | + | + | + |
| DS_39_NEG | Rat_14 | OD | retina | 14 | – | – | – | + | + | – |
| DS_40_POS | Rat_15 | OD | retina | 14 | – | – | – | + | + | + |
| DS_40_NEG | Rat_15 | OD | retina | 14 | – | – | – | + | + | – |
| DS_41_POS | Rat_13 | OS | retina | 14 | + | + | – | + | + | + |
| DS_41_NEG | Rat_13 | OS | retina | 14 | + | + | – | + | + | – |
| DS_42_POS | Rat_14 | OS | retina | 14 | + | + | – | + | + | + |
| DS_42_NEG | Rat_14 | OS | retina | 14 | + | + | – | + | + | – |
| DS_43_POS | Rat_15 | OS | retina | 14 | + | + | – | + | + | + |
| DS_43_NEG | Rat_15 | OS | retina | 14 | + | + | – | + | + | – |
| DS_44_POS | Rat_16 | OS | retina | 14 | + | – | + | + | + | + |
| DS_44_NEG | Rat_16 | OS | retina | 14 | + | – | + | + | + | – |
| DS_45_POS | Rat_17 | OS | retina | 14 | + | – | + | + | + | + |
| DS_45_NEG | Rat_17 | OS | retina | 14 | + | – | + | + | + | – |
| DS_46_POS | Rat_18 | OS | retina | 14 | + | – | + | + | + | + |
| DS_46_NEG | Rat_18 | OS | retina | 14 | + | – | + | + | + | – |
| DS_47_POS | Rat_19 | OS | retina | 14 | + | – | + | + | + | + |
| DS_47_NEG | Rat_19 | OS | retina | 14 | + | – | + | + | + | – |
LipidSearch nomenclature of the identified lipid species.
| Group | ClassKey | Lipid name |
|---|---|---|
| phospholipid | BisMePA | bismethyl phosphatidic acid |
| cPA | cyclic phosphatidic acid | |
| dMePE | dimethylphosphatidylethanolamine | |
| LdMePE | lysodimethylphosphatidylethanolamine | |
| LPC | lysophosphatidylcholine | |
| LPE | lysophosphatidylethanolamine | |
| LPI | lysophosphatidylinositol | |
| PA | phosphatidic acid | |
| PC | phosphatidylcholine | |
| PE | phosphatidylethanolamine | |
| PEt | phosphatidylethanol | |
| PG | phosphatidylglycerol | |
| PI | phosphatidylinositol | |
| PMe | phosphatidylmethanol | |
| PS | phosphatidylserine | |
| sphingolipid | Cer | ceramide |
| SM | sphingomyelin | |
| So | sphingosine | |
| glycosphingolipid | CerG1 | hexosyl ceramide |
| CerG3 | trihexosyl ceramide | |
| SoG1 | hexosyl sphingosine | |
| ST | sulfatide | |
| cardiolipin | CL | cardiolipin |
| neutral glycerolipid | DG | diglyceride |
| MG | monoglyceride | |
| TG | triglyceride | |
| steroid | ChE | cholesterol ester |
| ZyE | zymosterol | |
| coenzyme | Co | coenzyme |
| fatty esters | AcCa | acyl carnitine |
| WE | wax ester | |
| glycoglycerolipid | MGDG | monogalactosyldiacylglycerol |
| SQDG | sulfoquinovosyldiacylglycerol |
Fig. 3Dataset overview. (a–b) Abundance (average area) and (c–d) variability (% CV) distribution among treatment groups. Retina samples: (a–c). Optic nerve samples: (b–d). (e) Pearson's correlation coefficients between biological replicates within each treatment group. Mean + SD. (f–j) Principal component analysis (PCA) with samples plotted in 2 dimensions using their projection onto the first 2 principal components (in brackets % of total variance explained).
Fig. 4Data analysis example. (a–b) The number of significant features at different FDR adjusted p value cut-offs for one-way ANOVA analysis: species (a) and classes (b). (c–d) Accumulation change patterns of dysregulated species (FDR adjusted p-values <0.05) in the retina (370 species; c) and ON (324 species; d) 14 days post-crush, presented as heatmaps. Ward clustering algorithm, Euclidean distance measure, autoscale features. Species are not labeled for clarity.
Specifications table
| Subject area | Biology |
| More specific subject area | Lipids |
| Type of data | Chromatograms, spectra, tables |
| How data was acquired | LC-MS/MS |
| Data format | Raw, filtered, analyzed |
| Experimental factors | Intact, optic nerve crush + PBS, optic nerve crush + Zymosan + CPT-cAMP |
| Experimental features | Rat optic nerves were collected 3, 7, 14 and retinas 7, 14 days post-crush. After a chloroform-methanol based extraction, lipid samples were analyzed using high performance liquid chromatography with C30 column coupled to a Q Exactive mass spectrometer operated in a data-dependent mode. |
| Data source location | Bascom Palmer Eye Institute, Miller School of Medicine at University of Miami, Miami, FL 33,136, USA and The Metabolomics Workbench |
| Data accessibility | The Metabolomics Workbench -PR000661, |
| Related research article | Stark, D.T. et al., Optic Nerve Regeneration After Crush Remodels the Injury Site: Molecular Insights From Imaging Mass Spectrometry. Invest Ophthalmol Vis Sci, 2018.59(1): p. 212–222. |
The dataset can serve to inform future functional studies on the involvement of lipids in the RGCs injury and regeneration response. The dataset provides the information of the expression of lipids present in the rat retina and ON at the baseline and over time during injury and repair. Additionally, the data can be used to create lipid spectral libraries for the targeted lipidomic experiments. |